Loading
Life sciences · Journal article
Discover Chemistry. · July 27, 2026
Raises a question worth testing. It does not answer one.
This is a narrative review surveying the potential of metal-containing compounds as antimicrobial agents in response to antimicrobial resistance. The article presents mechanisms of action and highlights candidate metal ions (silver, copper, gold, gallium, bismuth, ruthenium) but does not report empirical efficacy data, clinical outcomes, or comparative trials. It identifies research directions and challenges rather than establishing evidence for a specific therapeutic claim.
Journal article.
Metallodrugs offer diverse mechanisms of action including membrane disruption, oxidative stress induction, and enzyme inhibition Key metal ions identified as antimicrobially active: silver, copper, gold, gallium, bismuth, and ruthenium Enhancement strategies proposed include rational ligand design, combination therapies, nanotechnology-driven delivery, and photoactivation
Toxicity concerns and resistance mechanisms are acknowledged but not quantified
This review may inform researchers and drug developers considering metallodrug approaches to resistance, but does not provide evidence sufficient to guide clinical practice or validate efficacy in any specific infection or population.
This is a narrative review article exploring the potential of metallodrugs as antimicrobials; it raises mechanistic questions and identifies opportunities rather than reporting empirical data from a controlled study with clinical outcomes.
This review may inform researchers and drug developers considering metallodrug approaches to resistance, but does not provide evidence sufficient to guide clinical practice or validate efficacy in any specific infection or population.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
The rising global concerns for antimicrobial resistance (AMR) urgently demands novel antimicrobial agents. Conventional antibiotics, which are purely based on organic moieties, are failing against multidrug-resistant (MDR) and pan-drug-resistant (PDR) pathogens, necessitating innovative therapeutic approaches. However, metallodrugs, compounds incorporating metal ions, have re-emerged as a promising class of antimicrobials. Historically used in medicine, their application declined with conventional antibiotics. However, metallodrugs offer unique chemical diversity, diverse mechanisms of action, and the ability to overcome established resistance pathways. This review explores their multifaceted actions, including membrane disruption, oxidative stress induction, and enzyme inhibition. Key metal ions like silver, copper, gold, gallium, bismuth, and ruthenium are highlighted for their antimicrobial applications and therapeutic potential. Advanced strategies for enhancing metallodrug efficacy include rational ligand design, combination therapies, nanotechnology-driven delivery systems, and photoactivation. While significant opportunities exist, challenges such as toxicity concerns, pharmacokinetic optimization, potential resistance mechanisms, and regulatory pathways must be addressed. This article provides a foundation for researchers and clinicians, emphasizing metallodrugs’ transformative potential in combating the AMR crisis and shaping infectious disease treatment.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.